Guide: How research is recorded

Regulatory approval

Regulatory approval is a regulator's decision that a treatment may be sold in its territory for a stated use, after reviewing the evidence its maker submitted.

This entry has not yet been checked by a person. It was written by software from the sources it lists. What “checked by a person” means

In the records

In the United States, the Food and Drug Administration (FDA) says approval of a drug means that its reviewers have examined the data on the drug’s effects and determined that its benefits outweigh its known risks for the intended population. The FDA does not test drugs itself; it reviews the evidence a company sends.

In the European Union the decision is called a marketing authorisation. The European Medicines Agency gives a scientific recommendation and the European Commission takes the binding decision. In the United Kingdom the Medicines and Healthcare products Regulatory Agency grants a marketing authorisation, also called a licence.

Some authorisations are conditional: granted on less comprehensive data than normally required, for serious conditions, and renewed each year.

What it does not tell you

An approval is for a stated use. It does not cover every condition a treatment has been reported for.

Each regulator decides for its own territory, so a decision by one is not a decision by another.

Authorised does not mean available or paid for. The European Medicines Agency says pricing and reimbursement are decided nationally and that it has no role in them.

A conditional authorisation rests on evidence that is still being completed.

On this site

If a regulator has recorded an approval of the treatment for the page's condition, the status is “Approved”. The decision is listed on the page as a record, with its date and a link to the regulator. The rule: How a status is set

Sources

Something wrong on this page? Tell us what, and the source that shows it: Report an error (opens your mail)